Complex sentence: Zoledronate (INN: zoledronic acid, marketed by Novartis under the trade names Zometa ® and Aclasta ®) is a bisphosphonate, used to prevent osteoporosis and skeletal fractures, particularly in patients with cancers such as multiple myeloma and prostate cancer.
Split into simpler sentences: Zoledronate (INN: zoledronic acid, marketed by Novartis under the trade names Zometa ® and Aclasta ®) is a bisphosphonate. Zometa is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer.